# 1. Financial Performance ## A. Key Figures * Consolidated Revenue: **₹91.5 Cr** H1 FY'26 (+15%) · **₹50.2 Cr** Q2 FY'26 (+6%) * **Assisted Care Revenue:** **₹3.91 Cr** Q2 (+1.3x QoQ, +2.1x YoY) * **EBITDA:** **-₹26 Cr** consolidated * **Treasury Assets:** **₹310 Cr** (as of Sep 30, 2025) * **Net Worth:** **₹467 Cr** (as of Sep 30, 2025) * **Liquidity:** **₹208 Cr** with **net debt fully repaid** ## B. Revenue Growth * **Broad-Based Momentum:** Strong double-digit H1 revenue growth across all verticals, supported by exceptional scaling in Assisted Care. * **Care Segment Breakout:** Assisted Care demonstrates exponential growth trajectory, now serving **3,000 patients** cumulatively in Care Homes. ## C. EBITDA & Margins * **Loss Continues Amid Investment Phase:** EBITDA remains negative as company prioritizes strategic cost optimization and high utilization to drive future profitability. ## D. Balance Sheet Strength * **Robust Financial Foundation:** Strong treasury and net worth provide durable capital base, enabling disciplined deployment into scalable growth opportunities. * **Growth-Focused Liquidity:** Fully repaid net debt and ring-fenced liquidity underscore commitment to funding expansion from internal strength. * **Transparency on Reporting:** Segment revenue differences reconciled via intercompany eliminations, including interest income at holding level. --- # 2. Care Operations & Utilization ## A. Key Figures * Care Homes Revenue: **₹6.2 Cr** (quarterly, Dehradun) * Care at Home Revenue: **INR5.24 crores** (highest quarterly, H1) (+1.1x QoQ, +1.3x YoY) * **Occupied Bed Days:** **6,765** (cumulative, quarterly) * **Patient Volume (Care at Home):** **>6,300** (H1) * **EBITDA:** **₹1 Cr** (Antara Residences, H1) · **-₹43 Cr** (Antara Assisted Care, H1) * **ARPOB:** **₹6,000–6,500/day** (₹20–22 L per bed annually) ## B. Care Homes Occupancy * **Occupancy Momentum:** Care Homes show rising utilization, with system-wide occupancy improving from 20% to 25% QoQ, supported by new bed additions and facility launches in key cities. * **Maturation Trajectory:** Individual facilities reflect staged ramp-up—mature Memory Care near 50% occupancy, while newer sites at 20–25%; full build-out expected within 8–10 quarters. * **Growth Drivers:** Digital acquisition and hospital partnerships are accelerating demand, with no expected near-term occupancy decline. * **Customer Experience:** High satisfaction (88%) and voice-of-customer scores (86–95%) indicate strong brand consistency across service lines. ## C. Care at Home Volume * **Strong Revenue & Margin Uptick:** Care at Home achieved record revenue on the back of high-margin services, with Bengaluru turning positive and Chennai improving contribution margin. * **Strategic Prioritization:** Growth is intentional but measured (~20% YoY, projected 20–30%), with focus on margin improvement over rapid scaling. * **Unit Economics:** Performance assessed at business level; **manpower** is the largest cost driver, with current CM1 ranging from **6% to 20%** across cities. ## D. ARPOB Trends * **Premium Pricing in South:** ARPOB is higher in Bangalore and Chennai due to greater market maturity and a higher mix of **transition care** patients requiring critical support. * **Revenue Stability:** ARPOB remains resilient at **₹6,000–6,500/day**, reflecting consistent pricing power across occupied beds. --- # 3. Product & Brand Performance ## A. Key Figures * **AGEasy Revenue:** **₹20.9 Cr** net (monthly run rate ₹7–8 Cr) (+1.5x QoQ) · **₹35 Cr** H1 FY26 (+3.3x YoY) * **RoAS:** **2** (+1x QoQ, +3x YoY) * **Contribution Margin:** **16%** (Sep-25) · **23%** (September exit rate) ## B. AGEasy Growth & Customer Engagement * **Exponential Scaling:** AGEasy achieved robust momentum across channels, driven by deepening customer engagement and a fully integrated ecosystem in core verticals. * **Customer Base Expansion:** Platform has served **5 lakh customers** since inception, including **50,000 repeat customers**, signaling strong retention and brand loyalty. * **Offline Rebound:** Offline sales surged with 4x QoQ growth following strategic shift to **Antara-branded products** and exit from third-party offerings. ## C. Product Mix & Margin Performance * **High-Quality Innovation:** 84% of 14 H1 launches received 4+ ratings, with **64% achieving gross margins above 50%**, reflecting strong product-market fit and pricing power. * **Margin Drivers:** Improved gross margins supported by **40% China-sourced inventory** and operational efficiencies, with contribution margin expanding to 23% by quarter-end. ## D. Innovation & Brand Development * **Product Portfolio Scale:** AGEasy now offers ~85 products across 180 SKUs, with **4 patents filed** (knee, diaper, nebulizer) to protect key innovations. * **Strategic Expansion:** Launch of **Gut Health nutraceutical line** in partnership with Wellbeing Nutrition (Mumbai) expected in November–December, extending ecosystem reach. * **Moat Building:** Plans to customize interventions for **top 10 selling products** to enhance differentiation and customer stickiness. --- # 4. Capacity & Expansion ## A. Key Figures * **Preferential Issue:** **₹80 Cr** raised via convertible warrants (₹40 Cr received, ₹40 Cr expected next year), primarily for residence vertical * **Project Collections:** **₹332 Cr** collected from Estate360 (99% efficiency), generating **₹27 Cr** in management fees (₹8 Cr in FY26) * **Capacity Target:** Scaling Assisted Care footprint to **500 operational beds by end-November** ## B. Bed Capacity Additions * **Capital Allocation:** Funding secured for expansion, with strong deployment into Assisted Care and future residence projects, signaling confidence in growth execution. * **Strategic Scaling:** Ambitious plan to launch **15 Cr sq ft** of inventory and scale Assisted Care to **500 beds** by November, with multi-year expansion roadmap in place. ## C. Residential Project Progress * **Proven Monetization:** Estate360 fully sold with near-perfect collection efficiency, demonstrating strong demand and reliable fee generation. * **Pipeline Momentum:** Next-phase project E361 launched in partnership with Max Estates, RERA filed, with first phase expected in mid-December '25. * **Development Velocity:** **1 Cr sq ft delivered** under Estate360 this year, with **0.5 Cr sq ft** of new supply expected within 6 months, indicating rapid execution. --- # 5. Customer & Channel Mix ## A. Key Figures * **Marketplace Contribution:** **12%–13%** of sales via Flipkart * **Retail Reach:** **600** chemist/retail touch points · **60** distributor partnerships ## B. Hospital Partnerships * **Strategic Focus:** Long-term hospital collaborations prioritized to drive **steady occupancy growth** in Care Homes. ## C. Digital Acquisition * **Channel Momentum:** Flipkart marketplace delivers **higher RoAS** and meaningful sales contribution, supporting digital channel efficiency. * **Marketing Evolution:** Celebrity partnerships show mixed results—strong performance on Google metrics but **low social media traction** despite YouTube focus. * **RoAS Trajectory:** Return on ad spend shows **significant improvement** (exit rate of 9), though sustainability and medium-term targets remain under discussion. * **Pricing Framework:** Care at Home uses **per-day, service-specific pricing** post-clinical assessment, with customization for long-term needs. ## D. Retail Distribution * **Product & Geographic Expansion:** Exclusive focus on AGEasy brand, now scaled to **North and expanding into South India** via 60 distributors and ~600 retail outlets. --- # 6. Risks & Regulatory Challenges ## A. Project OC Delays * **Supreme Court Awaits Final Ruling on Noida OC:** Occupancy certificate for Noida Sector 150 remains pending before the Supreme Court, with next hearing scheduled for **November 18, 2025**; project classified under **Category 2** by Noida Authority. * **Positive Precedent Builds Optimism:** Favorable outcome expected, supported by **Godrej’s precedent** in the same sector, despite orders not yet being issued post-Category 1 hearing. * **Project Ready for Possession:** All dues settled and proportional sports city obligations fulfilled; unit delivery awaits only regulatory clearance. * **Residential Expansion Behind Pace:** Growth lags annual 5 lakh sq ft target due to **Chandigarh project delays**, with limited completions across Estate360, Estate361, and Noida Phase 2. * **Chandigarh Revival in Progress:** Project not canceled; management actively evaluating **alternate land parcels within Chandigarh** for relaunch. ## B. Land & Zoning Issues * **Airport Proximity Hinders Chandigarh Clearance:** Despite being just **1 km from airport**, project stalled under government review of developments within **20-km airport radius**; no clearance granted to date. * **Diversified Land Sourcing Strategy:** Exploring alternative opportunities in **Bangalore and South India** while preserving existing partnerships. ## C. Competitive Intensity * **Sector Growth Fuels Visibility:** Rising competition in Senior Living, including entry of **marquee players**, is expanding market awareness and indirectly enhancing company’s **brand credibility**. * **Strategic Discipline in New Verticals:** Deliberate hold on quick commerce entry due to concerns over **low RoAS and unsustainable losses**, prioritizing capital efficiency. * **Regulatory Leadership Recognized:** Acknowledged by **NABH as early adopter for Care Homes** in Q2 FY26 and contributed to policy shaping via collaboration with **NITI Aayog**. --- # 7. Guidance & Outlook ## A. Breakeven Timeline * **Break-Even Target:** AGEasy on track to reach breakeven by **late FY27 or early FY28**, underpinned by disciplined investment in brand, technology, talent, and operations. * **Management Commitment:** Despite refraining from formal forward-looking statements, leadership reaffirmed the break-even goal, suggesting underlying confidence in current CM1 and CM2 progression. ## B. Growth Trajectory * **Pivotal Scaling Phase:** H1 FY26 marked a turning point with exponential scale-up and successful execution of foundational initiatives positioning the business for sustained momentum. * **Future Channel Expansion:** Quick commerce remains a strategic option, contingent on achieving efficiency and scale in core e-commerce operations; select product lines identified as suitable. ## C. Capital Deployment * **Project Economics Upward Revision:** Sales price improvements in the state sector expected to enhance project IRRs upon approval, supporting return objectives. * **Stable Development Pace:** Commitment to developing **15 crore sq. ft.** of business space annually reflects long-term capital allocation discipline.